About the Society
The MS Society is the UK's largest charity for people affected by Multiple Sclerosis (MS).We are a membership organisation but provide services to all.
The Society funds MS research, runs respite care centres, provides grants (financial assistance), education and training on MS. It produces numerous publications on MS and runs a freephone specialist Helpline.
We are committed to bringing high standards of quality health and social care within reach of everyone affected by MS and to encourage and support medical and applied research into its cause and control. We have a vision and mission for action across the UK.
With a network of branches & regions across the UK, the Society has a National Centre in London and national offices in Northern Ireland, Scotland and Wales/Cymru.
Governed by People affected by MS
As a membership organisation we involve the MS community in all of our activities while also offering membership benefits for the individual, visit the membership section for more details.
The MS Society board of trustees is elected from, and by, members of the MS Society. Every member has a right to vote in the elections and at the MS Society's annual general meeting.
Our Aims & Declaration
As a charity we aim to support and relieve people affected by MS, to encourage people affected by MS to attain their full potential by improving their conditions of life, and to promote and publish results from research into MS and allied conditions.Find out about some of the awards the Society has won; recent awards
Our Factfile
The Multiple Sclerosis Society was founded in 1953 and is governed by a voluntary Board of Trustees.Many of the Trustees have direct experience of living with MS. The Board is accountable to the Charity Commission and to its members.
Our Accounts
Spending wisely. Where the money comes from, and where it goes.Pharmaceutical and allied industries relations
Information on the policy and guidelines for relations between the MS Society and the pharmaceutical and allied industries can be downloaded below.Policy on relations with the pharmaceutical industry (72 kb)










